A model-based approach to predict individual weight loss with semaglutide in people with overweight or obesity.
Saved in:
| Title: | A model-based approach to predict individual weight loss with semaglutide in people with overweight or obesity. |
|---|---|
| Authors: | Strathe A; Novo Nordisk A/S, Søborg, Denmark., Horn DB; University of Texas McGovern Medical School, Houston, Texas, USA., Larsen MS; Novo Nordisk A/S, Søborg, Denmark., Rubino D; Washington Center for Weight Management, Arlington, Virginia, USA., Sørrig R; Novo Nordisk A/S, Søborg, Denmark., Tran MTD; Novo Nordisk A/S, Søborg, Denmark., Wharton S; York University, McMaster University and Wharton Weight Management Clinic, Toronto, Ontario, Canada., Overgaard RV; Novo Nordisk A/S, Søborg, Denmark. |
| Source: | Diabetes, obesity & metabolism [Diabetes Obes Metab] 2023 Nov; Vol. 25 (11), pp. 3171-3180. Date of Electronic Publication: 2023 Jul 09. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1463-1326 (Electronic) Linking ISSN: 14628902 NLM ISO Abbreviation: Diabetes Obes Metab Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
